Zacks Research Estimates Allstate’s Q4 Earnings (NYSE:ALL)

The Allstate Co. (NYSE:ALL) – Analysts at Zacks Research upped their Q4 2024 earnings per share (EPS) estimates for shares of Allstate in a note issued to investors on Wednesday, November 13th. Zacks Research analyst Z. Masood now anticipates that the insurance provider will earn $4.77 per share for the quarter, up from their previous estimate of $4.64. The consensus estimate for Allstate’s current full-year earnings is $16.07 per share. Zacks Research also issued estimates for Allstate’s Q1 2025 earnings at $5.11 EPS, Q3 2026 earnings at $4.68 EPS and FY2026 earnings at $18.27 EPS.

Several other equities research analysts have also recently commented on ALL. BMO Capital Markets increased their price target on Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Evercore ISI raised their target price on Allstate from $191.00 to $195.00 and gave the stock an “in-line” rating in a research note on Wednesday, October 9th. Barclays boosted their price target on shares of Allstate from $175.00 to $187.00 and gave the company an “underweight” rating in a research report on Thursday, October 31st. Keefe, Bruyette & Woods raised their price objective on shares of Allstate from $222.00 to $225.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 6th. Finally, UBS Group boosted their target price on shares of Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a report on Monday, November 4th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $214.19.

Allstate Stock Up 0.6 %

ALL stock opened at $196.88 on Friday. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43. The firm has a 50-day moving average of $189.79 and a two-hundred day moving average of $176.53. Allstate has a 12 month low of $131.65 and a 12 month high of $201.00. The company has a market cap of $52.13 billion, a price-to-earnings ratio of 12.81, a PEG ratio of 1.75 and a beta of 0.48.

Allstate (NYSE:ALL) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. The business had revenue of $16.63 billion during the quarter, compared to analysts’ expectations of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The company’s quarterly revenue was up 14.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.81 earnings per share.

Allstate Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be issued a $0.92 dividend. The ex-dividend date is Friday, November 29th. This represents a $3.68 annualized dividend and a dividend yield of 1.87%. Allstate’s dividend payout ratio is presently 23.83%.

Insider Buying and Selling

In other news, EVP Robert Toohey sold 16,682 shares of the company’s stock in a transaction on Monday, August 19th. The stock was sold at an average price of $180.17, for a total transaction of $3,005,595.94. Following the sale, the executive vice president now owns 4,873 shares of the company’s stock, valued at approximately $877,968.41. This represents a 77.39 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider John E. Dugenske sold 36,367 shares of the stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the sale, the insider now directly owns 27,364 shares in the company, valued at $5,236,922.32. This represents a 57.06 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 143,049 shares of company stock valued at $26,106,112. Corporate insiders own 1.80% of the company’s stock.

Institutional Investors Weigh In On Allstate

A number of large investors have recently modified their holdings of the company. BDF Gestion acquired a new position in shares of Allstate during the second quarter worth $3,051,000. OFI Invest Asset Management acquired a new position in shares of Allstate during the 2nd quarter worth about $476,000. Cetera Investment Advisers increased its holdings in shares of Allstate by 351.6% in the 1st quarter. Cetera Investment Advisers now owns 65,221 shares of the insurance provider’s stock valued at $11,284,000 after acquiring an additional 50,780 shares during the last quarter. Diversified Trust Co raised its position in shares of Allstate by 505.3% during the 2nd quarter. Diversified Trust Co now owns 7,923 shares of the insurance provider’s stock worth $1,265,000 after acquiring an additional 6,614 shares in the last quarter. Finally, Canada Pension Plan Investment Board lifted its stake in Allstate by 97.5% during the first quarter. Canada Pension Plan Investment Board now owns 271,464 shares of the insurance provider’s stock worth $46,966,000 after purchasing an additional 134,028 shares during the last quarter. 76.47% of the stock is owned by hedge funds and other institutional investors.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.